| Description | Crenezumab (MABT 5102A; RG 7412), a fully humanized monoclonal antibody targeting Aβ, exhibits binding affinity for various forms of Aβ, including soluble, oligomeric, and fibrillar. It is utilized in the study of Alzheimer's disease [1]. |
| molecular weight | N/A |
| CAS | 1095207-05-8 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 years | Shipping with blue ice. |